[1] Walter G, Vernier M, Pinelli P O, et al. Bone and joint infections due to anaerobic bacteria: an analysis of 61 cases and review of the literature[J]. European Journal of Clinical Microbiology & Infectious Diseases Official Publication of the European Society of Clinical Microbiology, 2014, 33(8):1355-1364. [2] 葛严萍, 马玉琴. 剖宫产术中甲硝唑冲洗预防感染效果观察[J].实用临床医药杂志, 2002, 6(6):569-569. [3] 陈秋燕. 克林霉素联合甲硝唑治疗细菌性阴道炎的疗效观察[J].临床合理用药杂志, 2013, 6(34):31-31. [4] Dickinson P A, Wang W L, Stott P W, et al. Clinical Relevance of Dissolution Testing in Quality by Design[J]. The AAPS Journal, 2008, 10(2):380-390. [5] 郝利华, 郭桂芳, 于晓辉,等. 溶出度测定在药物制剂研发与质量评价中的应用进展[J]. 中国兽药杂志, 2013, 47(6):67-69. [6] 金建平. 溶出度试验在药品质量控制中的应用[J]. 安徽医药,2006, 10(9):699-702. [7] Gao Y C, Zhuo W, Miao Y U, et al. Dissolution apparatus and quality consistency evaluation for generics[J]. Chinese Journal of New Drugs, 2015, 24(3):317-324. [8] Ming-Zhe X U, Niu J Z, Hua C, et al. Principle and policy for process management of consistency evaluation for generic drugs[J]. Chinese Journal of New Drugs, 2013, 22(21): 2475-2478. [9] Lan L, Niu J Z, Ming-Zhe X U, et al. Comparative analysis of consistency evaluation for generic drugs in foreign countries[J]. Chinese Journal of New Drugs, 2013, 22(21):2470-2474. [10] 国家药典委员会.中华人民共和国药典二部[M].北京:中国医药科技出版社, 2015: 212-213. [11] 谢沐风. 溶出曲线相似性的评价方法[J]. 中国医药工业杂志,2009, 40(4):308-311. [12] 陆泰远. 甲硝唑片溶出度影响因素的探讨[J]. 医药导报, 2001,20(6): 376-377. [13] 俞慧群, 卓开华. 6厂家多潘立酮片的溶出度考察[J]. 中国药师, 2010, 13(1):74-76. [14] 谢沐风, 操洪欣. 溶出度测定中的若干问题[J]. 中国医药工业杂志, 2006, 37(12):859-862. [15] 谢沐风. 药物溶液稳定性试验的验证方法与重要性[J]. 药物分析杂志, 2005,25(1):107-109. [16] 门铁军, 李敬波. 影响甲硝唑片溶出度的因素[J]. 黑龙江医药,2003,16(3):187-188. |